Patents Assigned to SYNERGENZ BIOSCIENCE LTD
  • Publication number: 20160076104
    Abstract: The present invention provides methods for the assessment of risk of developing chronic obstructive pulmonary disease (COPD), emphysema or both COPD and emphysema in smokers and non-smokers using analysis of genetic polymorphisms.
    Type: Application
    Filed: November 23, 2015
    Publication date: March 17, 2016
    Applicant: SYNERGENZ BIOSCIENCE LTD
    Inventor: Robert Peter Young
  • Publication number: 20140155287
    Abstract: The present invention provides methods for the assessment of risk of developing lung cancer in smokers and non-smokers using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's risk of developing lung cancer, and the suitability of a subject for an intervention in respect of lung cancer. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided.
    Type: Application
    Filed: January 13, 2014
    Publication date: June 5, 2014
    Applicant: SYNERGENZ BIOSCIENCE LTD
    Inventor: Robert Peter YOUNG
  • Publication number: 20140011863
    Abstract: The present invention provides methods for the assessment of risk of developing chronic obstructive pulmonary disease (COPD), emphysema or both COPD and emphysema in smokers and non-smokers using analysis of genetic polymorphisms.
    Type: Application
    Filed: September 13, 2013
    Publication date: January 9, 2014
    Applicant: SYNERGENZ BIOSCIENCE LTD
    Inventor: Robert Peter Young